a | 1F | Treatment | Normal | One-way ANOVA | <0.0001 | | |
| | Control vs Tat (4 h) | | Tukey’s post hoc | 0.5864* | –11.8% DSE | –22.5 to 0.13 |
| | Control vs Tat (24 h) | | Tukey’s post hoc | 0.0002* | –41.8% DSE | –55.6 to –27.4 |
| | Control vs Tat (48 h) | | Tukey’s post hoc | <0.0001* | –46.8% DSE | –60.7 to –32.8 |
| | Control vs hi-Tat (24 h) | | Tukey’s post hoc | 0.9759* | 4.6% DSE | –9.06 to 19.6 |
| | hi-Tat (24 h) vs Tat (24 h) | | Tukey’s post hoc | <0.0001* | –46.5% DSE | –63.2 to –30.2 |
| | hi-Tat (24 h) vs Tat (48 h) | | Tukey’s post hoc | <0.001* | –51.5% DSE | –68.7 to –36.6 |
b | | EPSC: control vs Tat (24 h) | Normal | Unpaired t test (two-tailed) | 0.3641 | –35.6 pA | –124.1 to 21.3 |
| | IPSC: control vs Tat (24 h) | Normal# | Welch’s t test (two-tailed) | 0.3406 | –97.5 pA | –329.3 to 68.3 |
c | 2D | Depolarization duration × Tat treatment | Normal | Two-way ANOVA: interaction | 0.9182 | | |
| | Depolarization duration | | Factor | 0.0007 | | |
| | Tat treatment | | Factor | 0.9365 | | |
d | 3C | Control vs Tat (24 h) | Normal | Unpaired t test (two-tailed) | 0.0001 | –24.5% MSE | –31.2 to –18.5 |
e | 4C | Tau: control vs Tat (24 h) | Normal | Unpaired t test (two-tailed) | 0.7611 | –0.4361 s | –3.554 to 2.680§ |
| | Peak: control vs Tat (24 h) | Normal | Unpaired t test (two-tailed) | 0.8827 | –0.0411 | –0.646 to 0.564§ |
f | 5C | 2-AG EC50: control vs Tat (24 h) | Normal# | Welch’s t test (two-tailed) | <0.0001 | 1.22 µM | 0.716 to 1.724§ |
| 5D | JZL184 treatment × Tat treatment | Normal | Two-way ANOVA: interaction | 0.8380 | | |
| | JZL184 treatment | | Factor | 0.3572 | | |
| | Tat treatment | | Factor | <0.0001 | | |
g | 6D | Win-2 EC50: control vs Tat (24 h) | Normal | Unpaired t test (two-tailed) | 0.93 | –0.16 nM | –3.81 to 4.13§ |
h | 7D | [THC] × Tat treatment | Normal | Two-way ANOVA: interaction | 0.9165 | | |
| | Tat treatment | | Factor | <0.0001 | | |
| | [THC] | | Factor | 0.0111 | | |
i | | RAP (24 h) × Tat (24 h) | Normal | Two-way ANOVA: interaction | 0.6978 | | |
| | RAP (24 h) treatment | | Factor | 0.9528 | | |
| | Tat (24 h) treatment | | Factor | <0.0001 | | |
j | 8B | CPA: control vs Tat (24 h) | Normal | Unpaired t test (two-tailed) | 0.6862 | 2.65% | –9.05 to 13.9 |
| 8C | CAP: control vs Tat (24 h) | Normal | Unpaired t test (two-tailed) | 0.8557 | –1.83% | –21.9 to 14.7 |